Omnitrope Purple Book BLA 021426

BLA number
021426
Proprietary names
Omnitrope
Proper names
somatropin
Applicant
Sandoz Inc.
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Omnitropesomatropin351(a)5.8MGFor InjectionSubcutaneousMulti-Dose VialRxLicensed2006-05-30
002Omnitropesomatropin351(a)1.5MGFor InjectionSubcutaneousSingle-Dose VialDiscLicensed2006-05-30
003Omnitropesomatropin351(a)5MG/1.5MLInjectionSubcutaneousMulti-Dose CartridgeRxLicensed2008-01-16
004Omnitropesomatropin351(a)10MG/1.5MLInjectionSubcutaneousMulti-Dose CartridgeRxLicensed2008-08-25

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2021-04-01U001Omnitrope351(a)RxSandoz Inc.
2021-04-01U002Omnitrope351(a)DiscSandoz Inc.
2021-04-01U003Omnitrope351(a)RxSandoz Inc.
2021-04-01U004Omnitrope351(a)RxSandoz Inc.
2020-05-01R001Omnitrope351(a)RxSandoz Inc.
2020-05-01R002Omnitrope351(a)DiscSandoz Inc.
2020-05-01R003Omnitrope351(a)RxSandoz Inc.
2020-05-01R004Omnitrope351(a)RxSandoz Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-05-01001Omnitrope351(a)RxLicensed2006-05-30
2020-05-01002Omnitrope351(a)DiscLicensed2006-05-30
2020-05-01003Omnitrope351(a)RxLicensed2008-01-16
2020-05-01004Omnitrope351(a)RxLicensed2008-08-25